Literature DB >> 15075990

Audit of a Barrett's epithelium surveillance database.

K K Basu1, B Pick, J S de Caestecker.   

Abstract

BACKGROUND: Barrett's epithelium is a premalignant condition in which endoscopic surveillance is recommended but remains contentious. AIM: To audit our Barrett's epithelium surveillance database and to calculate the incidence and natural history of dysplasia and cancer in this cohort.
METHODS: A retrospective analysis of a computerised database of patients with columnar lined oesophagus containing specialised intestinal metaplasia was undertaken over a 5-year period. The surveillance protocol was annual endoscopy with 2-cm interval quadrantic biopsies with patients on continuous acid-suppression therapy.
RESULTS: A total of 138 (102 men) patients underwent active surveillance. The mean age was 62.1 years and the mean Barrett's epithelium length was 5.9 cm. Ten patients had low-grade dysplasia, with a mean age of 73.5 years, a mean Barrett's epithelium length of 7.8 cm, a prevalence of 7.2% over 5 years and an incidence of 1.4% per annum. Low-grade dysplasia regressed in five patients, persisted in four patients, and was associated with a concurrent squamous carcinoma in one patient. Three patients had high-grade dysplasia at index endoscopy, with no incident cases. One progressed to adenocarcinoma after 2 years. A cancer incidence of one per 202 patient-years of surveillance was found, equivalent to 0.5% per year.
CONCLUSION: Short-interval (1-year) endoscopic surveillance of Barrett's epithelium offers little reward. Low-grade dysplasia is uncommon, and no progression to adenocarcinoma was seen in this cohort. No incident high-grade dysplasia was observed. Prospective evaluation of a longer endoscopic surveillance interval in controlled clinical studies is warranted.

Entities:  

Mesh:

Year:  2004        PMID: 15075990     DOI: 10.1097/00042737-200402000-00008

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  7 in total

Review 1.  Performance measures for upper gastrointestinal endoscopy: A European Society of Gastrointestinal Endoscopy quality improvement initiative.

Authors:  Raf Bisschops; Miguel Areia; Emmanuel Coron; Daniela Dobru; Bernd Kaskas; Roman Kuvaev; Oliver Pech; Krish Ragunath; Bas Weusten; Pietro Familiari; Dirk Domagk; Roland Valori; Michal F Kaminski; Cristiano Spada; Michael Bretthauer; Cathy Bennett; Carlo Senore; Mário Dinis-Ribeiro; Matthew D Rutter
Journal:  United European Gastroenterol J       Date:  2016-08-21       Impact factor: 4.623

Review 2.  Natural history of Barrett's esophagus.

Authors:  Rao Milind; Stephen E Attwood
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

3.  Improving surveillance for Barrett's oesophagus.

Authors:  Peter A Bampton; Anne Schloithe; Jeff Bull; Robert J Fraser; Rob T A Padbury; David I Watson
Journal:  BMJ       Date:  2006-06-03

4.  Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus.

Authors:  Cathy Bennett; Susi Green; John DeCaestecker; Max Almond; Hugh Barr; Pradeep Bhandari; Krish Ragunath; Rajvinder Singh; Janusz Jankowski
Journal:  Cochrane Database Syst Rev       Date:  2020-05-22

5.  Surveillance in Patients With Barrett's Esophagus for Early Detection of Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis.

Authors:  Yao Qiao; Ayaz Hyder; Sandy J Bae; Wasifa Zarin; Tyler J O'Neill; Norman E Marcon; Lincoln Stein; Hla-Hla Thein
Journal:  Clin Transl Gastroenterol       Date:  2015-12-10       Impact factor: 4.488

6.  Progression from low-grade dysplasia to malignancy in patients with Barrett's esophagus diagnosed by two or more pathologists.

Authors:  Harsha Moole; Jaymon Patel; Zohair Ahmed; Abhiram Duvvuri; Sreekar Vennelaganti; Vishnu Moole; Sowmya Dharmapuri; Raghuveer Boddireddy; Pratyusha Yedama; Naveen Bondalapati; Achuta Uppu; Prashanth Vennelaganti; Srinivas Puli
Journal:  World J Gastroenterol       Date:  2016-10-21       Impact factor: 5.742

7.  Predictable Marker for Regression of Barrett's Esophagus by Proton Pump Inhibitor Treatment in Korea.

Authors:  Hyun Jin Jo; Hye Seung Lee; Nayoung Kim; Ryoung Hee Nam; Hyun Chang; Min Soo Kim; Sung Eun Kim; Jane C Oh; Dong Ho Lee; Hyun Chae Jung
Journal:  J Neurogastroenterol Motil       Date:  2013-04-16       Impact factor: 4.924

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.